DexCom
DXCM
200 hedge funds and large institutions have $2.97B invested in DexCom in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 13 closing their positions.
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
5% more funds holding
Funds holding: 190 → 200 (+10)
2% more capital invested
Capital invested by funds: $2.9B → $2.97B (+$70.5M)
13% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 80
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less call options, than puts
Call options by funds: $2.86M | Put options by funds: $3.55M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$42.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$30M |
| 3 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$22M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.5M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
+$20.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.7M |
| 2 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
-$21M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$20.5M |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$15M |
| 5 |
Millennium Management
New York
|
-$11.7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ST
201
SpiderRock Trading
Chicago,
Illinois
| $1K | – | – | – |
|
|
FA
202
Friess Associates
Greenville,
Delaware
| – | -$15M | -1,517,472 | Closed |
|
203
Nomura Holdings
Tokyo,
Japan
| – | -$2.98M | -300,252 | Closed |
|
|
CCM
204
Catapult Capital Management
New York
| – | -$1.39M | -140,000 | Closed |
|
205
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$1.19M | -120,000 | Closed |
|
|
CSS
206
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$656K | -66,144 | Closed |
|
|
CEI
207
Clark Estates Inc
New York
| – | -$595K | -60,000 | Closed |
|
|
PG
208
PEAK6 Group
Chicago,
Illinois
| – | -$460K | -46,388 | Closed |
|
|
GAM
209
Gotham Asset Management
New York
| – | -$319K | -32,132 | Closed |
|
210
Natixis Advisors
Boston,
Massachusetts
| – | -$273K | -27,508 | Closed |
|
|
YP
211
Yellowstone Partners
Idaho Falls,
Idaho
| – | -$255K | -25,760 | Closed |
|
|
VFA
212
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$254K | -25,572 | Closed |
|
213
JP Morgan Chase
New York
| – | -$207K | -20,856 | Closed |
|
|
IRS
214
Invictus RG (Singapore)
Singapore
| – | -$19K | -1,940 | Closed |
|
DXCM Hedge Fund Activity: Q3 2014 in Review
200 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2014, worth a combined $2.97B — up 2.4% from $2.9B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new DXCM positions and 13 closed out — a net gain of 13 holders — while 70 added to existing stakes and 80 trimmed.
The largest buyer was Wells Fargo, adding an estimated $42.9M. The largest seller was Fidelity Investments, cutting an estimated $25.7M.
- 200 institutional investors held DexCom (DXCM) as of Q3 2014, up from 190 in Q2 2014.
- Funds reported $2.97B of DexCom stock for Q3 2014, up 2.4% quarter-over-quarter.
- 26 funds opened new DexCom positions in Q3 2014 and 13 closed out, a net change of +13 holders.
- The largest DexCom buyer in Q3 2014 was Wells Fargo, an estimated $42.9M added.
- The largest DexCom seller in Q3 2014 was Fidelity Investments, an estimated $25.7M sold.
Based on aggregated 13F filings for Q3 2014.